Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions he has had with NICE on (a) reviewing and (b) updating (i) clinical guidelines and (ii) guidance on diagnosing Type 1 Diabetes and Eating Disorders.

The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for determining whether its guidelines should be reviewed or updated in the light of new evidence. NICE takes a proactive approach to surveillance, monitoring for changes in the evidence base that may impact on its recommendations. Topics for new or updated guidance are considered through the NICE prioritisation process. Decisions as to whether NICE will create new, or update existing, guidance are overseen by a prioritisation board, chaired by NICE’s chief medical officer.

NICE’s guidelines on the diagnosis and management of type 1 diabetes in adults, with the reference code NG17, diabetes, including both type 1 and type 2, in children and young people, with the reference code NG18, and the recognition and treatment of eating disorders, with the reference code NG69, will be reviewed if there is new evidence that is likely to change the recommendations. NICE currently has no plans to update NG17, NG18, or NG69.